Tertiary Prevention in Colon Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Tertiary Prevention in Colon Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

TerminatedPhase 2

NCT03047837

A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients

It has been shown that Aspirin (ASA) as well as Metformin (Met) can inhibit the incidence and mortality of colorectal cancer (CRC). In this randomized, placebo…

Italy160 participantsStarted 2017-03-15

Treatment: ASA, MET

CompletedNot Applicable

NCT01991847

Tertiary Prevention by Exercise in Colorectal Cancer Therapy

The purpose of this study is to determine the feasibility of a one year exercise training program in post-surgical patients with colorectal cancer.

Germany50 participantsStarted 2014-01

Treatment: Physical activity